Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2020	$ 1,114,828	$ 107,583	$ 1,041,507	$ (34,262)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(56,602)		(56,602)
Issuance of common stock	9,380	523	8,857
Stock-based compensation expense	10,345		10,345
Contribution of shares to a deferred compensation trust	1,485	23	1,462
Purchase of common stock	(108,321)	(1,086)	(107,235)
Other comprehensive income (loss)	4,850			4,850
Net earnings	253,452		253,452
Balance at end of period at Apr. 30, 2021	1,229,417	107,043	1,151,786	(29,412)
Balance at beginning of period at Jan. 29, 2021	1,179,722	107,613	1,104,285	(32,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(28,191)		(28,191)
Issuance of common stock	3,151	173	2,978
Stock-based compensation expense	5,829		5,829
Purchase of common stock	(76,029)	(743)	(75,286)
Other comprehensive income (loss)	2,764			2,764
Net earnings	142,171		142,171
Balance at end of period at Apr. 30, 2021	1,229,417	107,043	1,151,786	(29,412)
Balance at beginning of period at Oct. 31, 2021	1,151,132	105,206	1,071,922	(25,996)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(62,954)		(62,954)
Issuance of common stock	2,280	153	2,127
Stock-based compensation expense	11,133		11,133
Contribution of shares to a deferred compensation trust	(33)	(33)	0
Purchase of common stock	(76,850)	(758)	(76,092)
Other comprehensive income (loss)	(1,827)			(1,827)
Net earnings	200,635		200,635
Balance at end of period at Apr. 29, 2022	1,223,516	104,568	1,146,771	(27,823)
Balance at beginning of period at Jan. 28, 2022	1,119,549	104,529	1,040,634	(25,614)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(31,485)		(31,485)
Issuance of common stock	1,097	44	1,053
Stock-based compensation expense	5,908		5,908
Purchase of common stock	(469)	(5)	(464)
Other comprehensive income (loss)	(2,209)			(2,209)
Net earnings	131,125		131,125
Balance at end of period at Apr. 29, 2022	$ 1,223,516	$ 104,568	$ 1,146,771	$ (27,823)